All companies
Visit website
Chareau
OperatingCharron Favreau LLC
Food & Beverage
The world's first all-natural aloe liqueur. Over 100% growth in 2018
Post-money valuation ⓘ
$16.4M
As of Dec 2024 · from Chareau Common Stock 4 · pre-money + amount raised, not a traded price
Total raised
$429,534
Across 5 rounds since 2017
Latest share price
$2.55
Chareau Common Stock 4 offering price
Financials
FY2014–FY2023 · from SEC filings · hover any figure for its source$282K
−$207K
2016
$416K
−$698K
2017
$924K
−$830K
2018
$974K
−$766K
2019
$491K
−$627K
2020
$1.2M
−$666K
2021
$1.4M
−$2.3M
2022
$1.7M
−$1.3M
2023
RevenueNet income — beside revenue when positive, below the line when a loss
Chart shows the most recent 8 fiscal years; 2 earlier years are in the table below.
Metric
FY2014
FY2015
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
Income statement
Revenue
$153,812
$261,248
$282,237
$415,763
$924,007
$974,126
$491,122
$1,204,284
$1,419,257
$1,688,716
Cost of goods sold
$106,780
$108,395
$94,037
$190,981
$429,966
$480,374
$170,675
$398,966
$656,384
$798,137
Gross margin
31%
59%
67%
54%
53%
51%
65%
67%
54%
53%
Net income
-$113,686
-$93,897
-$207,479
-$697,798
-$829,767
-$766,288
-$627,052
-$666,197
-$2,275,235
-$1,313,826
Taxes paid
$800
$800
$0
$0
$0
$21,065
$7,211
$5,967
$0
$0
Balance sheet
Cash
$20,324
-$4,099
-$3,434
-$28,707
-$70,670
-$34,240
$39,433
$345,259
$458,055
$11,706
Accounts receivable
$25,775
$31,424
$32,430
$29,226
$40,126
$80,588
$39,290
$154,169
$161,898
$132,137
Total assets
$184,958
$205,750
$308,323
$587,181
$531,898
$444,613
$581,588
$1,145,492
$1,925,067
$1,015,184
Short-term debt
$11,159
$150,003
$34,208
$56,393
$90,201
$287,374
$509,668
-$221,456
$539,941
$646,423
Long-term debt
$0
$0
$250,846
$1,186,005
$1,835,749
$973,295
$1,426,280
$785,469
$788,708
$787,748
Total liabilities
$11,159
$150,003
$285,054
$1,242,398
$1,925,950
$1,260,669
$1,935,948
$564,013
$1,328,649
$1,434,171
Other
Headcount
—
3
—
8
—
2
4
10
7
4
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$6.6M
post-money
$12.3M
post-money
$16.4M
post-money
Chareau 2
Chareau Stock 3
Chareau Common Stock 4
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $84.6K / $600KInvestors 59Post-money $16.4M
Raised $224.5K / $250KInvestors 343Post-money $12.3M
Chareau 2Closed
Reg CF annual-report compliance
Not required3+ reports filed & assets ≤ $10M
Filed 6 of 10 annual reports (FY2016–FY2025)
343 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 23 filings on EDGARSource: ManualCIK 0001698872Share price $2.55
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.